According to a comprehensive report from The Insight Partners, 'dPCR and qPCR Market Size and Forecast 2022 - 2030, Global ...
Diagnostics Market is witnessing steady growth, with an estimated market valuation of USD 5.93 billion in 2023. The market is expected to expand at a CAGR of 5.81% from 2024 to 2032, driven by rising ...
In 2021, the market was valued at USD 912.5 million, and it is projected to reach USD 1,841.2 million by 2028, growing at a CAGR of 11.0% during 2022-2028. Key factors driving this growth include: The ...
Q4 2024 Earnings Call Transcript February 26, 2025 Operator: Good morning. Welcome to the Lantheus Fourth Quarter and Full Year 2024 Conference Call. [Operator Instructions]. This call is being ...
Prostate imaging drug Pylarify has become the first radiodiagnostic blockbuster, achieving over $1 billion in sales for 2024. The addressable market continues to expand.
Techne's strong growth in Protein Sciences & Spatial Biology despite market pressure. Explore more details here.
The Santa Clara, California-based firm said that its diagnostics and life sciences revenues rose 4 percent year over year.
According to FutureWise analysis the market for Artificial Intelligence in Digital Pathology in 2023 is US$ 0.33 billion, and is expected to reach US$ 1.17 billion by 2031 at a CAGR of 17%.Digital ...
GenAI, while analyzing vast and complex genetic and molecular data, is expected to help healthcare ... of strength in the ...
The growing demand for nucleic acid amplification testing (NAAT) is primarily fueled by the increasing prevalence of infectious and genetic diseases. Additionally, this demand is reinforced by the ...
Myriad Genetics (NASDAQ:MYGN – Get Free Report) had its price objective dropped by investment analysts at UBS Group from ...